NASDAQ:SQNM Sequenom (SQNM) Stock Price, News & Analysis → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free SQNM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$2.39▼$2.3950-Day Range N/A52-Week Range$0.82▼$2.53VolumeN/AAverage Volume1.27 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Sequenom alerts: Email Address Ad Paradigm PressMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. About Sequenom Stock (NASDAQ:SQNM)Sequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company's diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories' test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.Read More Ad Paradigm PressMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. SQNM Stock News HeadlinesMay 16, 2024 | morningstar.comUltimate Sports Inc USPSSeptember 9, 2023 | thestreet.com5 Biotech Stocks Under $10 Set to SoarJune 18, 2024 | Colonial Metals (Ad)The asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire investors are buying right along with them. Even Warren Buffett put over $500 million into gold. And with the help of a tax and penalty-free "Trump Loophole, " these investors are investing retirement into gold and other precious metals without having to put up any of their own cash. In our Free Precious Metals Guide, we reveal all the details on how the rich use this loophole to protect and growth their retirement wealth in any economy…and show you how you can use it too.July 23, 2023 | thestreet.comSequenom Fallout Hits Hedge FundsMay 18, 2023 | reuters.comLatest Markets NewsFebruary 27, 2023 | thestreet.comSequenom Still Very Good, Just No Longer PerfectJanuary 7, 2023 | thestreet.comPast Sequenom Exec Charged with Lying by SECOctober 19, 2022 | streetinsider.comJUNO DIAGNOSTICS STRENGTHENS THE ORGANIZATION WITH APPOINTMENT OF GINA GRAYUM TO COMMERCIAL LEADERSHIP TEAM - StreetInsider.comJune 18, 2024 | Colonial Metals (Ad)The asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire investors are buying right along with them. Even Warren Buffett put over $500 million into gold. And with the help of a tax and penalty-free "Trump Loophole, " these investors are investing retirement into gold and other precious metals without having to put up any of their own cash. In our Free Precious Metals Guide, we reveal all the details on how the rich use this loophole to protect and growth their retirement wealth in any economy…and show you how you can use it too.October 18, 2022 | prnewswire.comJUNO DIAGNOSTICS STRENGTHENS THE ORGANIZATION WITH APPOINTMENT OF GINA GRAYUM TO COMMERCIAL LEADERSHIP TEAM - PR NewswireOctober 12, 2022 | globenewswire.comPrenatal and Newborn Genetic Testing Market to hit US$ 12.70 Billion by 2030 | Exclusive Report by Growth Plus Reports - GlobeNewswireOctober 10, 2022 | globenewswire.comViral Antigens Market to Reach US$ 0.292 billion by 2030 Size, Shares, Forecasts, and Trends Analysis Report with COVID-19 Impact by Growth Plus Reports - GlobeNewswireSeptember 23, 2022 | seekingalpha.comInvitae: Losses & Debt Suggest Bearish Sentiment Is Deserved - Seeking AlphaSeptember 19, 2022 | businesswire.comWorld Non-Invasive Prenatal Testing (NIPT) Pipeline Market Report 2022: Comparative Analysis at Various Stages of Development and Information on Clinical Trials in Progress - ResearchAndMarkets.com - Business WireSeptember 7, 2022 | businesswire.comAnsa Bio Appoints Lorna Neilson, Ph.D. as Chief Business Officer - Business WireJuly 1, 2022 | globenewswire.comThe Worldwide Carrier Screening Industry is Expected to Reach $3.64 Billion by 2030 - GlobeNewswireJune 29, 2022 | uk.finance.yahoo.comThe Worldwide Carrier Screening Industry is Expected to Reach $3.64 Billion by 2030 - Yahoo Finance UKJune 23, 2022 | prnewswire.comNew Analysis from Global Industry Analysts Reveals Steady Growth for Genotyping, with the Market to Reach $39.9 Billion Worldwide by 2026 - PR NewswireJune 23, 2022 | finance.yahoo.comNew Analysis from Global Industry Analysts Reveals Steady Growth for Genotyping, with the Market to Reach $39.9 Billion Worldwide by 2026 - Yahoo FinanceJune 5, 2022 | seekingalpha.comLaboratory Corp: 15% Reward Asymmetry Under-Reflected, Seeking Exit At $280 Per Share - Seeking AlphaMay 31, 2022 | finance.yahoo.comAadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corporate Communications - Yahoo FinanceMay 13, 2022 | law360.comFed. Circ. Says LabCorp Missed Chance To Move Patent Row - Law360April 6, 2022 | prnewswire.comIDEAYA Biosciences Appoints Catherine Mackey, Ph.D., to its Board of Directors - PR NewswireMarch 9, 2022 | businesswire.comGlobal Non-invasive Prenatal Testing Market Report 2022: By Type, End User, Instruments, Consumables and Application - ResearchAndMarkets.com - Business WireFebruary 7, 2022 | finance.yahoo.comAmbrx Biopharma Inc. Appoints Paul Maier to Board of Directors and as Chair of the Audit Committee - Yahoo FinanceFebruary 7, 2022 | businesswire.comAmbrx Biopharma Inc. Appoints Paul Maier to Board of Directors and as Chair of the Audit Committee - Business WireFebruary 7, 2022 | streetinsider.comAmbrx Biopharma (AMAM) Appoints Paul Maier to Board of Directors and as Chair of the Audit Committee - StreetInsider.comSee More Headlines Receive SQNM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sequenom and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:SQNM CUSIP81733740 CIK1076481 Webwww.sequenom.com Phone+1-858-2029000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key CompetitorsThermo Fisher ScientificNYSE:TMOAgilent TechnologiesNYSE:AMettler-Toledo InternationalNYSE:MTDWatersNYSE:WATIlluminaNASDAQ:ILMNView All Competitors SQNM Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Sequenom own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sequenom investors own include Arch Resources (ARCH), PotlatchDeltic (PCH), Illumina (ILMN), LinnCo (LNCOQ), Conatus Pharmaceuticals (CNAT), DryShips (DRYS), La Jolla Pharmaceutical (LJPC), NovoCure (NVCR), Acer Therapeutics (ACER) and Aeterna Zentaris (AEZS). This page (NASDAQ:SQNM) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | Sponsoredwhy 99.94% won’t make you moneyI believe there's only 5-7 stocks that you should trade in 2024. But here's the catch…because there's alway...Prosper Trading Academy | SponsoredThe Hidden Anchor Investment of the Elite RevealedThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because sav...Colonial Metals | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sequenom Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Sequenom With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
